Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Johnson and Johnson
Chinese Patent Office
Teva
Julphar
QuintilesIMS
McKesson
Argus Health
AstraZeneca

Generated: October 18, 2018

DrugPatentWatch Database Preview

TRIAMCINOLONE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for triamcinolone and what is the scope of triamcinolone patent protection?

Triamcinolone is the generic ingredient in twenty-nine branded drugs marketed by Astellas, Delcor Asset Corp, Barr, Impax Labs, Ivax Sub Teva Pharms, Mylan, Purepac Pharm, Roxane, Sandoz, Teva, Watson Labs, Abbvie, Sanofi Aventis Us, Ivax Pharms, Solvay, Actavis Mid Atlantic, Alkem Labs Ltd, Alpharma Us Pharms, Ambix, Fougera Pharms, G And W Labs, Glenmark Pharms Ltd, Lannett Co Inc, Lupin Atlantis, Macleods Pharms Ltd, Morton Grove, Mylan Pharms Inc, Perrigo New York, Pharmaderm, Pharmafair, Taro, Taro Pharm Inds Ltd, Teligent Pharma Inc, Topiderm, Crown Labs, Savage Labs, Flexion Theraps Inc, Apothecon, Amneal Pharms Co, Parnell, Sandoz Inc, Allergan, Novartis Pharms Corp, Akorn, G And W Labs Inc, Wockhardt Bio Ag, Glenmark Pharms, Cmp Pharma Inc, Lyne, Perrigo Israel, Sun Pharm Inds Inc, Perrigo Uk Finco, Riconpharma Llc, and Fosun Pharma, and is included in one hundred and fifty NDAs. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fifty-one drug master file entries for triamcinolone.

Medical Subject Heading (MeSH) Categories for TRIAMCINOLONE
Synonyms for TRIAMCINOLONE
(11beta,16alpha)-9-Fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
(1R,2S,10S,11S,13R,14S,15S,17S)-1-fluoro-13,14,17-trihydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadeca-3,6-dien-5-one
(1R,2S,10S,11S,13R,14S,15S,17S)-1-FLUORO-13,14,17-TRIHYDROXY-14-(2-HYDROXYACETYL)-2,15-DIMETHYLTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-3,6-DIEN-5-ONE
(1R,2S,10S,11S,13R,14S,15S,17S)-1-fluoro-13,14,17-trihydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-dien-5-one
(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one
11-beta,16-alpha,17-alpha,21-Tetrahydroxy-9-alpha-fluoro-1,4-pregnadiene-3,20-dione
11.beta.,16.alpha.,17.alpha., 21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11.beta.,16.alpha.,17.alpha.,21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11.beta.,17.alpha.,21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11beta,16alpha,17alpha,21-Tetrahydroxy-9alpha-fluoro-1,4-pregnadiene-3,20-dione
124-94-7
124T947
1ZK20VI6TY
4-08-00-03629 (Beilstein Handbook Reference)
51855-44-8
83474-03-7
9-alpha-Fluoro-11-beta,16-alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-alpha-Fluoro-16-alpha-hydroxyprednisolone
9-Fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.Alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahy
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.Alpha.-Fluoro-11.beta.,16.alpha.,17.alpha., 21-tetrahydroxypregna-1,4-diene-3,20-d
9.alpha.-Fluoro-11.beta.,16.alpha.,17.alpha., 21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-11.beta.,16.alpha.,17.alpha.,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-11.beta.,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9.alpha.-Fluoro-11.beta.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-11.beta.,17.alpha.,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-16.alpha.-hydroxyprednisolone
9|A-Fluoro-11|A,16|A,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione; Fluoxyprednisolone
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-Fluoro-11beta,16alpha,17alpha,21-tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-Fluoro-16alpha-hydroxyprednisolone
AB1010916
AC-2072
AC1L1LDH
AC1Q5HJC
Adcortyl
AKOS015895436
AN-14322
Aristocort
Aristocort (TN)
Aristocort Tablets
AS-13657
BC214769
BDBM41132
Bio-0662
BPBio1_000154
BRD-K77554836-001-03-3
BRN 2341955
BSPBio_000140
C21H27FO6
CAS-124-94-7
CCG-205253
Celeste
CHEBI:9667
CHEMBL1451
cid_31307
Cinolone
Cinolone-T
CL 19823
CS-2370
D00385
D03BLF
DB00620
Delphicort
droxypregna-1,4-diene-3,20-dione
DSSTox_CID_20742
DSSTox_GSID_40742
DSSTox_RID_79584
DTXSID1040742
EINECS 204-718-7
EU-0101179
Fluoxiprednisolone
Fluoxyprednisolone
Fougera
Fougera (TN)
GFNANZIMVAIWHM-OBYCQNJPSA-N
GTPL2870
HMS1568G22
HMS2090D12
HMS2095G22
HMS2231E20
HMS3263L19
HSDB 3194
HY-B0328
J10062
Kenacort
Kenacort (TN)
Kenacort-AG
Ledercort
Lopac0_001179
LP01179
LS-698
MFCD00010477
MLS000028542
MLS001066543
MLS002695935
MolPort-002-528-981
Mycolog
NCGC00021580-03
NCGC00021580-04
NCGC00021580-05
NCGC00021580-06
NCGC00021580-07
NCGC00021580-08
NCGC00094799-01
NCGC00178404-03
NCGC00254049-01
NCGC00261864-01
NCI60_000750
NSC 13397
NSC-13397
NSC13397
Omcilon
Omicilon
PL043586
Prednisolone, 9-fluoro-16.alpha.-hydroxy-
Prednisolone, 9-fluoro-16alpha-hydroxy-
Pregna-1,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11.beta.,16.alpha.)-
Pregna-1,20-dione, 9-fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-
Pregna-1,4-diene-3, 20-dione, 9-fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-
Pregna-1,4-diene-3,20-dio
Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,16-alpha,17,21-tetrahydroxy-
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11-beta,16-alpha)-
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11.beta.,16.alpha.)-
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11beta,16alpha)
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11beta,16alpha)-
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11beta,16alpha)-, tetrahydro deriv.
Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,16alpha,17,21-tetrahydroxy-
Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,16alpha,17,21-tetrahydroxy- (8CI)
Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,16alpha,17,21-tetrahydroxy-(8CI)
Prestwick_438
Prestwick0_000120
Prestwick1_000120
Prestwick2_000120
Prestwick3_000120
Rodinolone
s1933
SC-46306
SCHEMBL4447
SK-Triamcinolone
SMP1_000300
SMR000058333
SPBio_002079
SR-01000000079
SR-01000000079-3
Tiamcinolonum
Tiamcinolonum [INN-Latin]
Tox21_111332
Tox21_111332_1
Tox21_300178
Tox21_501179
Tri-Nasal (TN)
Triaderm
Triam-Tablinen
Triamcet
Triamcinalone
Triamcinlon
Triamcinolon
Triamcinolona
Triamcinolona [INN-Spanish]
Triamcinolone (Aristocort)
Triamcinolone (JP15/USP/INN)
Triamcinolone (JP17/USP/INN)
TRIAMCINOLONE (SEE ALSO TRIAMCINOLONE ACETONIDE (76-25-5) AND TRIAMCINOLONE DIACETATE (67-78-7))
Triamcinolone [USAN:INN:BAN:JAN]
Triamcinolone, British Pharmacopoeia (BP) Reference Standard
Triamcinolone, European Pharmacopoeia (EP) Reference Standard
Triamcinolone, United States Pharmacopeia (USP) Reference Standard
Triamcinolonum
Triamcinolonum [INN]
Tricortale
Tricortone (TN)
Triderm (TN)
Triesence (TN)
Trilone
Trilone (TN)
Tristoject
Tristoject (TN)
UNII-1ZK20VI6TY
Volon
Volon A (TN)
WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ GQ
ZINC3882036

US Patents and Regulatory Information for TRIAMCINOLONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms TRIAMCINOLONE ACETONIDE triamcinolone acetonide LOTION;TOPICAL 040467-002 Apr 21, 2003 AT RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teligent Pharma Inc TRIAMCINOLONE ACETONIDE triamcinolone acetonide OINTMENT;TOPICAL 208590-001 Mar 3, 2017 AT RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
G And W Labs TRIAMCINOLONE ACETONIDE triamcinolone acetonide CREAM;TOPICAL 089797-001 May 31, 1991 AT RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
G And W Labs Inc TRIAMCINOLONE ACETONIDE triamcinolone acetonide OINTMENT;TOPICAL 208925-001 Oct 6, 2017 AT RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lannett Co Inc TRIAMCINOLONE ACETONIDE triamcinolone acetonide LOTION;TOPICAL 040672-002 Dec 13, 2006 AT RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Akorn TRIAMCINOLONE ACETONIDE triamcinolone acetonide PASTE;DENTAL 206312-001 Aug 11, 2016 AT RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Johnson and Johnson
Chinese Patent Office
Teva
Julphar
QuintilesIMS
McKesson
Argus Health
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.